Cyprotex Discovery Ltd.

About Cyprotex Discovery Ltd.

Cyprotex Discovery Ltd. is a leading provider of drug discovery and development services, specializing in the fields of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) testing. Established in the UK, the company has built a strong reputation for delivering high-quality data that supports the pharmaceutical and biotechnology industries in their quest to develop new therapeutics.

With a focus on innovation, Cyprotex Discovery employs cutting-edge technologies and methodologies to provide comprehensive solutions tailored to the specific needs of its clients. The company’s core activities include in vitro and in vivo testing, predictive modelling, and consultancy services aimed at optimizing drug candidates early in the development process.

Cyprotex Discovery is committed to advancing scientific knowledge and improving patient outcomes through its research initiatives. The company collaborates with academic institutions and industry partners to stay at the forefront of scientific advancements and regulatory requirements.

In addition to its technical expertise, Cyprotex Discovery prides itself on its customer-centric approach, ensuring that clients receive personalized support throughout their projects. The team of experienced scientists and project managers work closely with clients to understand their goals and deliver results that exceed expectations.

As part of its vision, Cyprotex Discovery aims to contribute to the global effort of bringing safe and effective drugs to market faster and more efficiently. The company’s dedication to quality, integrity, and innovation positions it as a trusted partner in the drug development landscape.

• Core Services: ADMET testing, predictive modelling, consultancy
• Industry Focus: Pharmaceutical and biotechnology sectors
• Commitment: Advancing scientific knowledge and improving patient outcomes